is tirzepatide on the market (Mounjaro): Novel Solution For Management Of Type 2 Diabetes And Obesity A Major GLP-1 Drug Shortage

Because they act over a few hours patients have their hunger greatly reduces the period in which someone feels hungry, leading to a reduction in eating and therefore weight loss

J.HuynhL.et al

To use, one simply licks a biosensor strip

#MDPI #OpenAccess #Biomedicines #Microbiota #GutBrainAxis #HydrogenSulfide #AlzheimersDisease #ParkinsonsDisease #Neuroinflammation #Probiotics Role of Microbiota-Derived Hydrogen Sulfide (H2S) in Modulating the GutBrain Axis: Implications for Alzheimers and Parkinsons Disease Pathogenesis mdpi.com To view or add a comment, sign in The Next Frontier in Metabolic Medicine: Dual and Triple Agonists Targeting Obesity and MASH Were entering a transformative phase in metabolic therapeutics

The timeline reflects the lag between AMPK activation, mitochondrial biogenesis, and the physiological adaptation required for sustained fat oxidation

And thats why theres a problem with the program that we need more transparency and accountability for these hospitals to disclose this to the patients